Original ResearchFull Report: Clinical—LiverLedipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Keywords
Abbreviations used in this paper
Cited by (0)
Conflicts of interest These authors disclose the following: Michael Charlton has received research support and grants from Gilead; Gregory Everson has received research support and grants from AbbVie, BMS, Eisai, Gilead, Janssen, Merck, and Roche/Genentech, and has served on advisory boards for AbbVie, BMS, Gilead, Janssen, and Merck; Princy Kumar has served as a consultant for Janssen and ViiV Healthcare, and is a stock shareholder of GSK, Gilead, J&J, Merck, and Pfizer; Charles Landis has received research support and grants from AbbVie, BMS, and Gilead; Robert Brown Jr has received research support and grants from Gilead, and has served as a consultant for Gilead; Norah Terrault has received research support and grants from Gilead; Jacqueline O'Leary has served as a consultant for AbbVie, Janssen, and Gilead, and was on the speakers bureau for AbbVie and Gilead; Hugo Vargas has received research support and grants from AbbVie, BMS, Eisai, Gilead, and Merck; Alexander Kuo has received research support and grants from Gilead, and has served as a consultant for AbbVie; Eugene Schiff has received research support and grants from Abbot, BMS, Beckman Coulter, Conatus, Discovery Life Sciences, Gilead, MedMira, Merck, Orasure Technologies, Roche Molecular, Janssen, and Siemens, has received personal fees from Acorda, Arrowhead, BMS, Gilead, Merck, Janssen, Pfizer, and Salix, and has received nonfinancial support from Merck and Salix; Mark Sulkowski has received research support and grants from AbbVie, BMS, Gilead, Janssen, and Merck, has served as a consultant for AbbVie, BMS, Gilead, Janssen, and Merck, has served on an advisory board for Gilead, and has been involved with the National Institutes of Health; Richard Gilroy has received research support and grants from Gilead, and has received personal fees from AbbVie, Gilead, NPS, and Salix; Kymberly Watt has served as a sponsor for Gilead; Kimberly Brown has received research support and grants from AbbVie, BMS, Centers for Disease Control Foundation, Gilead, Hyperion, Janssen, and Vertex, has served as a consultant for AbbVie, BMS, Gilead, Janssen, and Merck, has served on the speakers bureau for AbbVie, CLDF, Gilead, HCV Viewpoints, and Simply Speaking, has served on advisory boards for AJT Images, AST Past, CLDF, and CLD Journal, and was involved with Medscape; Paul Kwo has received research support and grants from AbbVie, BMS, Conatus, Gilead, Janssen, Merck, Roche, and Vertex, has served as a consultant for Gilead, has served on advisory boards for AbbVie, BMS, Gilead, Janssen, Merck, Novartis, and Vertex, and was on the speakers’ bureau for Merck and Vertex; Surakit Pungpapong has received research support and grants from BMS and Gilead; Andrew Muir has received research support and grants from Gilead, and has served on advisory boards for Gilead; Robert Fontana has received research support and grants from BMS, Gilead, Janssen, and Vertex; K. Rajender Reddy has received research support and grants from AbbVie, BMS, Genentech-Roche, Gilead, Janssen, Merck, and Vertex, has served as a consultant for AbbVie, BMS, Genentech-Roche, Gilead, Idenix, Janssen, Merck, and Vertex, has served on advisory boards for CLDF and Novartis, and has received payment for the development of educational presentations from ViralEd; Nezam Afdhal has received research support and grants from AbbVie, BMS, and Gilead, has served on advisory boards for Gilead, has served as a consultant for Gilead, and has received personal fees from AbbVie, Achillion, BMS, Merck, Janssen, and SprinBank; and Jill Denning, Sarah Arterburn, Theo Brandt-Sarif, Phillip Pang, and John McHutchison are employees of Gilead. The remaining authors disclose no conflicts.
Funding Supported by Gilead Sciences. Gilead Sciences collected the data, monitored the study conduct, and performed the statistical analyses.
- §
Authors share co-senior authorship.